passiv
immun
mice
pg
nonneutr
monoclon
antibodi
mab
direct
subgroup
epitop
g
glycoprotein
respiratori
syncyti
viru
long
strain
rsv
confer
protect
viral
challeng
role
fc
fragment
antibodi
well
involv
antibodydepend
cellular
cytotox
adcc
complementmedi
cytolysi
toward
protect
evalu
vivo
passiv
immun
fab
fragment
alon
pg
mous
unabl
confer
protect
mice
furthermor
passiv
immun
mab
scid
beig
mice
defici
natur
killer
nk
cell
activ
ascertain
role
nk
cell
protect
mechan
mice
free
viru
day
follow
viral
challeng
indic
nk
cell
contribut
signtficantli
toward
protect
action
antibodi
moreov
passiv
immun
balbic
mice
decompl
u
cobra
venom
factor
covf
mice
defici
partial
protect
find
suggest
mice
altern
classic
pathway
complement
system
involv
passiv
protect
mechan
confer
nonneutr
mab
knowledg
thefirst
descript
protect
mechan
mice
involv
nonneutr
antibodi
complement
system
copyright
elsevi
scienc
ltd
respiratori
syncyti
viru
caus
sever
lower
respiratori
tract
diseas
infant
children
sever
year
f
g
glycoprotein
rsv
scrutini
prospect
develop
effect
innocu
studi
involv
character
potenti
antigen
immunogen
site
f
g
glycoprotein
reveal
b
epitop
involv
neutral
passiv
protect
shown
subgroup
specif
antigen
site
locat
within
amino
acid
region
glycoprotein
furthermor
previous
demonstr
synthet
peptid
consist
amino
acid
confer
protect
balbc
mice
intranas
challeng
rsv
long
strain
passiv
immun
mab
centr
de
recherch
en
virologi
lnstitut
armandfrappi
universitb
du
quebec
boul
de
prairi
laval
quebec
canada
tto
correspond
address
receiv
juli
revis
octob
accept
octob
direct
epitop
also
mediat
antivir
effect
vivo
neutral
activ
vitro
observ
suggest
fc
portion
mab
may
play
critic
role
toward
protect
vivo
either
adcc
respons
complementmedi
cytolysi
complementdepend
virolysi
studi
examin
mechan
involv
protect
mice
follow
passiv
immun
mab
protect
potenti
mab
investig
scid
mice
defici
b
cell
function
scid
beig
mice
defici
b
nk
cell
polymorphonuclear
pmn
cell
furthermor
complement
deplet
balbc
mice
mice
defici
compon
complement
use
evalu
role
complement
system
protect
final
ifni
deplet
balbc
mice
allow
us
evalu
contribut
ifn
toward
antivir
effect
observ
balbc
mice
passiv
immun
mab
result
demonstr
pathway
complement
protect
mice
corbeil
et
al
system
involv
protect
mice
passiv
immun
nonneutr
mab
direct
subgroup
epitop
glycoprotein
g
rsv
long
strain
balbc
mice
purchas
charl
river
laboratori
stconstant
qc
scid
scid
beig
mice
purchas
charl
river
laboratori
wilmington
mice
c
defici
strain
lack
jackson
laboratori
bar
harbor
mice
femal
day
old
long
strain
respiratori
syncyti
viru
atcc
american
type
cultur
collect
rockvil
md
propag
cell
atcc
previous
grown
equal
part
eagl
minim
essenti
medium
medium
gibco
laboratori
grand
island
ny
supplement
pug
ml
gentamicyn
vv
fetal
calf
serum
fc
infect
monolay
incub
serumfre
medium
viru
titrat
carri
flatbottom
microtit
plate
cell
x
cell
well
medium
confluent
cultur
remov
tenfold
dilut
viru
ad
well
case
viru
obtain
lung
extract
solut
ad
tenfold
dilut
min
adsorpt
period
ml
serum
medium
ad
well
plate
incub
day
humidifi
atmospher
contain
co
viral
syncytia
count
titer
express
tissu
cultur
infecti
dose
log
tcid
purif
mab
carri
standard
proteinasepharos
chromatographi
fab
fragment
mab
obtain
papain
digest
briefli
mg
purifi
mab
digest
acet
mm
ethylenediaminetetraacet
acid
edta
buffer
ph
mg
papain
sigma
chemic
co
st
loui
mo
preactiv
mm
cystein
sigma
h
reaction
mixtur
pass
twice
proteinasepharos
column
elimin
fc
fragment
undigest
antibodi
purifi
fab
fragment
dialyz
phosphat
buffer
salin
solut
pb
gibco
ph
store
use
puriti
fragment
evalu
standard
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
nonreduc
condit
coomassi
blue
stain
follow
densitometri
laser
densitomet
biorad
mississauga
ontario
activ
mab
fab
fragment
determin
elisa
passiv
protect
studi
group
mice
immun
intraven
iv
pg
mab
immedi
challeng
intranas
lo
tcid
rsv
long
strain
five
day
follow
challeng
mice
kill
lung
test
presenc
viru
titrat
assay
complement
deplet
achiev
inject
baja
nuja
cobra
venom
factor
covf
sigma
mous
receiv
dose
u
use
follow
schedul
rout
inocul
challeng
occur
time
h
h
h
via
ip
rout
h
h
h
h
postchalleng
via
iv
rout
time
mice
receiv
pug
mab
iv
challeng
describ
previous
case
describ
anim
kill
day
challeng
lung
test
presenc
viru
titrat
assay
deplet
ifni
acheiv
inject
antiifni
antibodi
cedarlan
laboratori
horbi
ontario
via
iv
rout
mous
receiv
ug
antibodi
h
challeng
addit
mous
receiv
ug
mab
iv
min
challeng
anim
kill
day
challeng
lung
test
presenc
viru
titrat
assay
three
hundr
nanogram
per
well
rsv
control
antigen
purifi
sucros
densiti
step
gradient
centrifug
wv
adsorb
overnight
flatbottom
microtit
plate
plate
wash
block
min
pb
contain
fc
gibco
laboratori
grand
island
ny
vv
mab
fab
fragment
serial
dilut
pb
supplement
fc
tween
ad
h
incub
plate
wash
dilut
horseradish
peroxidaselabel
rabbit
antimous
igg
cappel
scarborough
ontario
goat
antimous
igg
fabspecif
antibodi
sigma
ad
well
plate
incub
h
wash
reaction
develop
ophenylenediamin
mg
ml
sodium
citrat
ph
contain
vv
hzo
result
express
invers
last
serum
dilut
gave
read
averag
read
plu
two
standard
deviat
isotyp
mab
control
neutral
assay
carri
microtit
plate
mab
lqo
incub
overnight
presenc
absenc
mous
complement
sigma
mixtur
ad
mix
viral
suspens
contain
tcid
ml
rsv
long
strain
neutral
reaction
allow
proceed
h
virusantibodi
mixtur
ad
plate
contain
cell
sheet
incub
min
addit
ul
wv
methylcellulos
semisolid
cultur
medium
incub
period
protect
mice
cofbeil
et
al
order
character
protect
mechan
confer
mice
ug
mab
passiv
immun
balbc
mice
either
mab
purifi
fab
fragment
challeng
mice
rsv
long
strain
mab
prevent
replic
rsv
lung
treat
mice
tabl
howev
mice
receiv
ug
fab
fragment
show
signific
reduct
viral
titr
lung
ttest
level
comparison
control
mice
receiv
intranas
challeng
tabl
observ
consist
observ
made
oldston
et
fab
fragment
almost
total
ineffect
lysi
viral
infect
cell
lamarr
show
fab
fragment
neutral
mab
direct
glycoprotein
murin
hepat
viru
requir
tenfold
amount
whole
antibodi
achiev
level
protect
mice
experi
complet
absenc
protect
observ
passiv
transfer
pug
fab
fragment
suggest
fc
fragment
n
b
play
import
role
passiv
protect
unfortun
abl
evalu
protect
potenti
antibodi
bival
use
f
ab
sinc
isotyp
degrad
upon
digest
pepsin
scid
mice
lymphocyt
hypogammaglobulinaem
defici
immun
function
mediat
b
immun
scid
mice
mab
determin
whether
b
cell
play
role
protect
confer
mice
receiv
mab
total
protect
control
mice
averag
viral
titer
tcid
total
protect
observ
passiv
immun
scid
mice
suggest
passiv
protect
mab
depend
bor
tcell
function
previou
studi
report
mice
express
beig
mutat
bgbg
nk
defect
appear
lie
within
lytic
machineri
nk
use
beig
mice
proven
valuabl
studi
cytomegaloviru
lymphocyt
choriomening
viru
infect
absenc
function
nk
previou
observ
presenc
fc
fragment
may
requir
protect
mice
brought
forward
possibl
nk
cell
could
involv
via
adcc
mechan
order
test
hypothesi
use
beig
mous
model
would
allow
viva
abrog
nk
cell
activ
studi
total
protect
scid
beig
mice
passiv
immun
mab
tabl
suggest
nk
cell
lysi
virusinfect
cell
contribut
significantli
toward
protect
action
mab
cobra
venom
factor
known
anticomplementari
effect
vitro
vim
particularli
third
fifth
compon
complement
moreov
role
altern
classic
pathway
complement
system
host
recoveri
viral
infect
document
oldston
et
al
ls
show
crosslink
polyoma
viral
particl
presenc
viral
surfac
play
signific
role
neutral
viru
import
clearanc
polyomaantibodi
complex
shown
delay
remov
complex
serum
vivo
carri
experi
use
covf
ascertain
whether
inhibit
classic
altern
pathway
would
affect
immun
protect
observ
mice
passiv
immun
mab
balbc
mice
treat
covf
averag
viral
titer
tcid
lung
approx
looofold
higher
averag
titer
tcid
mice
passiv
immun
mab
tabl
howev
complementdeplet
mice
averag
viral
titer
lower
mice
control
group
passiv
immun
complementdeplet
tcid
result
show
balbc
mice
deplet
complement
covf
treatment
protect
follow
viral
challeng
sinc
inactiv
complex
covf
affect
also
find
strongli
suggest
least
one
pathway
complement
system
involv
observ
protect
mice
mab
data
consist
result
obtain
hirsch
et
show
looofold
viru
present
brain
complementdeplet
mice
similar
observ
role
complement
system
made
hick
et
concern
complement
deplet
mice
undergo
sever
infect
influenza
virus
comparison
normal
mice
order
clarifi
role
classic
pathway
alon
protect
use
mice
defici
compon
complement
system
tabl
show
six
dbau
mice
passiv
immun
mab
two
protect
four
mice
low
averag
viral
lung
titer
tcid
control
mice
passiv
immun
mab
show
high
averag
viral
titer
tcid
comparison
mice
deplet
complement
covf
treatment
csdefici
mice
lower
viral
titer
lung
ttest
data
seem
indic
classic
pathway
character
action
involv
lesser
extent
protect
infect
cell
result
suggest
complement
system
may
show
differ
mechan
action
respect
type
mab
involv
neutral
nonneutr
shown
administr
antiifni
serum
enhanc
mortal
mice
infect
herp
simplex
viru
rais
viru
titer
lymphocyt
choriomening
vaccinia
infect
organ
studi
attempt
evalu
effect
ifni
complementari
mechan
protect
mice
result
show
three
mice
inject
antiifni
antibodi
passiv
immun
mab
total
protect
mice
passiv
immun
mab
ifn
deplet
tabl
find
suggest
particip
ifni
observ
protect
mab
unlik
conclus
also
support
fact
unabl
detect
ifni
sera
mice
vaccin
peptid
result
shown
studi
demonstr
complement
system
partial
involv
protect
mice
passiv
immun
mab
challeng
rsv
long
strain
howev
deplet
complement
system
appear
suffici
total
abrog
protect
mice
passiv
immun
mab
macrophag
monocyt
known
notabl
viral
phagocyt
properti
cytokin
product
could
confer
complementari
protect
anim
model
hypothesi
yet
verifi
